Trump Signs Executive Order Supporting State-Run Psychedelics Programs

President Donald Trump (R) last week signed an executive order to make certain psychedelic drugs more available to treat some mental health conditions. The order directs $50 million in federal funds to make the drugs more accessible via state-run programs, and requires the Food and Drug Administration (FDA) to expedite a review of some psychedelic drugs, including psilocybin and ibogaine. 

The order includes a provision that would require “timely rescheduling” of any current Schedule 1 substance that successfully completes Phase 3 clinical trials for a serious mental health disorder.   

The standard medical or psychiatric treatment may not be effective for individuals with major depressive disorders and substance use disorder.  Our medical system, despite massive Federal investments in researching possible advancements in mental healthcare and treatment has not yet produced approved therapies which promote lasting improvements in the mental condition of these complex patients.  “Innovative methods must be used to provide long-term treatment for Americans who are suffering from mental illness beyond the prescription medication they currently take.” — “Accelerating Medical Treatments for Serious Mental Illness” Executive Order, 4/18/26  

In a video of Trump signing the order, podcaster Joe Rogan, who attended the ceremony, noted that “These drugs are illegal not because they are harmful” but “because of the 1970 Controlled Substances Act.” 

Rogan: “For 56 Years we lived in those horrible conditions.” “We’re free of that now, we’re free of that now.”    

The order also includes the creation of a voucher program for “appropriate psychedelic drugs” that have received a Breakthrough Therapy designation and are in line with the criteria of the National Priority Voucher Program.

Since the President’s executive order telling federal agencies to speed up the process of re-scheduling cannabis, there have been no new developments.

Cannabis Law Resources in Poland

Browse essential legal pages on cannabis sales and cultivation in Poland. You can use these resources to learn about the requirements for certifications, permissions and compliance.

• 
  Polish News Registration and Interests of Cannabis Businesses
  
• 
  Permissions for Cannabis Sales in Poland
  
• 
  Authorization for Importing or Manufacturing Medical Products
  
• 
  Permission for Manufacturing or Importing Medical Products
  
• 
  Certificate of Good Manufacturing Practices (GMP)
  
• 
  Registration of Medical Products in Poland